Friday 6 November 2026 Export RNXT’s income statement to Excel — free account

RenovoRx, Inc.

RNXT Healthcare Biotechnology

RenovoRx, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 million, up 2,511.6% from fiscal 2024.

Revenue: +300.8%
EPS: 0.00%
Free cash flow: −12.7%

Quarter to September 2026, against a year earlier

Insider buying

1.14 0.05 −4.20%

Follow RNXT

Alert me

Market cap: $53.7M
P/E: 0.0×
Fwd P/E: −5.1×
Dividend yield: —
F-score: n/a
Altman Z: −8.04
Beneish M: 19.25
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26 From the 10-Q filed 5 Nov
ROE Full definition →	+8 more TTM periods Free account	(225.62%)	(100.47%)	(125.23%)	(149.98%)
ROA Full definition →		(137.77%)	(81.85%)	(97.83%)	(110.14%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(187.92%)	(103.30%)	(136.20%)	(132.69%)
Average Days of Receivables Full definition →		45.18	68.64	88.66	80.07
Free Cash Flow per Share Full definition →		(0.31)	(0.30)	(0.25)	(0.25)
Free Cash Flow Full definition →		(10.97)	(11.30)	(11.94)	(12.22)
Capital Expenditures Full definition →		0.00	—	(0.07)	(0.09)
Other line items
Cash ROIC Full definition →		(88.18%)	(47.83%)	(64.67%)	(62.09%)
Accounts Receivable Turnover Full definition →		12.34	5.71	4.69	7.14
Accounts Payable Turnover Full definition →		0.47	0.30	0.40	0.49
Inventory Turnover Full definition →		0.00	0.00	0.00	1.45
Average Days of Payables Full definition →		891.85	1,288.44	1,026.27	772.84
Days of Inventory on Hand Full definition →		210.96	436.39	453.88	280.96
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		558.24%	393.22%	284.87%	186.78%
Selling, General and Administrative Expense of Revenue Full definition →		626.63%	549.76%	484.77%	386.31%
Share Based Compensation of Revenue Full definition →		112.82%	87.04%	76.97%	59.11%
Operating CF/Net income Full definition →		0.98	0.92	0.97	0.93
Depreciation/Fixed assets Full definition →		0.17	0.03	0.06	0.13
Capex/Depreciation Full definition →		(1.00)	0.00	(11.83)	(7.50)
Revenue per Share Full definition →		0.03	0.04	0.04	0.06
Operating CF per Share Full definition →		(0.31)	(0.30)	(0.25)	(0.25)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.04	0.03

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly